Clinical Trial Update: Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial in autism spectrum disorder uses a multimodal approach including cSVF, stored mesenchymal stem cells, fecal microbiota trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Diet modification
• Fecal microbiota transplant (fecal microbiota transplant)
• Stored Mesenchymal Stem Cells (mesenchymal stem cells)
• cSVF (cellular stromal vascular fraction)

Snippet

Sponsor: Black Tie Medical, Inc. | Conditions: Autism Spectrum Disorder, Autism | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION